L.C. Chaplin
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
Papers in
-
- Radiopharmaceutical Chemistry and Applications 4
- Monoclonal and Polyclonal Antibodies Research 4
- Co-authors
- Andrew M. Nesbitt (4 shared papers)Mark Bodmer (2 shared papers)J.S. Emtage (2 shared papers)Adrienne Morgan (2 shared papers)Nick D. Jones (1 shared paper)Spencer Emtage (2 shared papers)Mark Sopwith (1 shared paper)Chris R. Bebbington (1 shared paper)
- Journals
- British Journal of Cancer (3 papers)Journal of Chromatography A (2 papers)Clinical Chemistry (1 paper)Annals of the Rheumatic Diseases (1 paper)Immunotechnology (1 paper)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
L.C. Chaplin
15 papers receiving 492 citations
Peers
Comparison fields: 5 of 53
- Radiology, Nuclear Medicine and Imaging 279
- Immunology 47
- Cellular and Molecular Neuroscience 33
- Rheumatology 26
- Immunology and Allergy 8
Countries citing papers authored by L.C. Chaplin
This map shows the geographic impact of L.C. Chaplin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.C. Chaplin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.C. Chaplin more than expected).
Fields of papers citing papers by L.C. Chaplin
This network shows the impact of papers produced by L.C. Chaplin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.C. Chaplin. The network helps show where L.C. Chaplin may publish in the future.
Co-authors
The 25 scholars most cited alongside L.C. Chaplin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Comprehensive pharmacokinetics of a humanized antibody and analysis of residual anti-idiotypic responses. | 1995 | 104 |
| 2 | The N-terminal end of the CH2 domain of chimeric human IgG1 anti-HLA-DR is necessary for C1q, Fc gamma RI and Fc gamma RIII binding. | 1995 | 95 |
| 3 | 1991 | 66 | |
| 4 | 1994 | 57 | |
| 5 | 1996 | 44 | |
| 6 | 2002 | 38 | |
| 7 | 1991 | 35 | |
| 8 | 1986 | 30 | |
| 9 | 1985 | 22 | |
| 10 | 1995 | 21 | |
| 11 | 1987 | 14 | |
| 12 | 1997 | 9 | |
| 13 | 1988 | 5 | |
| 14 | 1998 | 4 | |
| 15 | Band-8 protein of human erythrocyte membrane: another Ca++ binding protein? | 1984 | 3 |
About L.C. Chaplin
L.C. Chaplin is a scholar working on Radiology, Nuclear Medicine and Imaging, Spectroscopy, Molecular Biology, Analytical Chemistry and Cell Biology, having authored 15 papers that have together received 547 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Protein purification and stability (2 papers), Analytical Methods in Pharmaceuticals (1 paper), Protein Structure and Dynamics (1 paper), ATP Synthase and ATPases Research (1 paper), Proteins in Food Systems (1 paper) and Rheumatoid Arthritis Research and Therapies (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (279 citations), Immunology (47 citations), Cellular and Molecular Neuroscience (33 citations), Rheumatology (26 citations) and Immunology and Allergy (8 citations). L.C. Chaplin has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Andrew M. Nesbitt, Mark Bodmer, J.S. Emtage, Adrienne Morgan, Nick D. Jones, Spencer Emtage, Mark Sopwith, Chris R. Bebbington, R. Barbara Pedley and Joanne L. Casey. Their work appears in journals such as British Journal of Cancer, Journal of Chromatography A, Clinical Chemistry, Annals of the Rheumatic Diseases and Immunotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.